JBS N.V.
NYSE:JBSPackaged Foods
-$0.34 today
- Market cap
- $26.66B
- Beta
- 0.17
- P/E (TTM)
- 6.9
- EPS (TTM)
- $8.91
- Dividend yield
- 8.41%
Volume 9.80M
Average 6.65M
JBS Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
JBS N.V.NYSE: JBS
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables turns positive
Q3 FY2026 accounts receivables was $1.54B, compared with -$1.32B a year earlier. Trailing-twelve-month accounts receivables was -$981.52M. Over 3 fiscal years it compounded at +3.7% a year.
Context
- Accounts receivables amounted to 0.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $1.54B or moves back toward the trailing-twelve-month quarterly average of -$245.38M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
BRL · from the cash flow
- Latest · FY2025
- (1.45B) BRL
- Year-over-year change
- +28.2%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.45B) | +28.2% |
| FY2024 | 2024-12-31 | (2.02B) | -164.5% |
| FY2023 | 2023-12-31 | 3.13B | +341.0% |
| FY2022 | 2022-12-31 | (1.3B) | +69.6% |
| FY2021 | 2021-12-31 | (4.27B) | — |
Accounts Receivables vs competitors
How JBS compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -40.3% is the lowest of 4, against a peer median of +511.0%.
- Accounts receivables amounts to 0.3% of revenue for JBS, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
JBSJBS N.V. | LTM Jun 2026 | R$981.52M BRL | -40.3% | +3.7% | 0.3% |
| LTM Jun 2026 | $201.26M USD | +511.0% | +811.1% | 1.1% | |
| LTM Jul 2026 | $64.92M USD | +293.3% | +4.9% | 0.5% | |
| LTM Oct 2026 | $56M USD | +722.2% | — | 0.5% | |
| LTM Oct 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | +142.4% | 0.0% | |
| Peer median (excluding JBS) | — | +511.0% | +142.4% | 0.5% | |
Competitors are the stored peer set for JBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 20.49B | 15.46B | (1.06B) | 9.62B | 11.1B |
| Depreciation & Amortization | 9.03B | 10.05B | 10.38B | 11.95B | 12.63B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (361.42M) |
| Stock-Based Compensation | 63.43M | 39.13M | 34.42M | 85.6M | 0 |
| Change in Working Capital | (20.84B) | (8.85B) | 3.41B | (7.34B) | (11.86B) |
| Accounts Receivables | (4.27B) | (1.3B) | 3.13B | (2.02B) | (1.45B) |
| Inventory | (11.79B) | (6.78B) | (300.66M) | (4.73B) | (4.58B) |
| Accounts Payables | 0 | 0 | 0 | 0 | 3.01B |
| Other Working Capital | (4.78B) | (774.46M) | 580.45M | (592.03M) | (8.85B) |
| Other Non-Cash Items | 12.74B | (3.36B) | (1.26B) | 9.24B | 3.99B |
| Operating Cash Flow | 21.48B | 13.33B | 11.5B | 23.56B | 15.49B |
| Capital Expenditures | (9.62B) | (11.23B) | (7.49B) | (8.08B) | (11.37B) |
| Acquisitions (Net) | (9.34B) | (1.98B) | (17.16M) | (31.46M) | 394.77M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (1.26B) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 102.65M | 81.04M | 485.19M | 382.02M | (285.38M) |
| Investing Cash Flow | (18.86B) | (13.12B) | (7.02B) | (7.73B) | (12.56B) |
| Debt Repayment | 17.73B | 264.72M | 7.45B | (1.65B) | 7.15B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (10.6B) | (3.65B) | 0 | (44.49M) | (3.19B) |
| Dividends Paid | (7.4B) | (4.44B) | (2.22B) | (4.44B) | (8.81B) |
| Other Financing Activities | (575.4M) | (939.51M) | (218.37M) | (1.16B) | (5.12B) |
| Financing Cash Flow | (844.5M) | (8.76B) | 5.01B | (7.3B) | (9.97B) |
| Effect of Forex Changes | 1.78B | (1.51B) | (545.05M) | 4.11B | 1.32B |
| Net Change in Cash | 3.56B | (10.06B) | 8.94B | 12.64B | (5.71B) |
| Free Cash Flow | 11.86B | 2.11B | 4.01B | 15.47B | 4.13B |
JBS N.V.
NYSE:JBS
Intrinsic Alpha fair value
Locked
Current Price
$12.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.